Clariane (BATS-CHIXE:CLARIP) - Stock Price, News & Analysis

CLARIP Stock Overview

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues.

About the company

CLARIP fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	0/6
Financial Health	0/6
Dividends	3/6

Rewards

Trading at 68.1% below our estimate of its fair value

Earnings are forecast to grow 33.04% per year

Risk Analysis

Shares are highly illiquid

Interest payments are not well covered by earnings

Dividend of 11.7% is not well covered by earnings

Large one-off items impacting financial results

+ 1 more risk

Clariane SE Competitors

CVS Group

AIM:CVSG

UK£661.3m

Spire Healthcare Group

LSE:SPI

UK£965.1m

Mediclinic International

LSE:MDC

UK£3.7b

Integrated Diagnostics Holdings

LSE:IDHC

US$218.7m

Price History & Performance

Summary of all time highs, changes and price drops for Clariane
Historical stock prices
Current Share Price	€3.38
52 Week High	€9.68
52 Week Low	€3.38
Beta	1.03
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-89.24%
5 Year Change	-89.14%
Change since IPO	-71.51%

Recent updates

Shareholder Returns

	CLARIP	GB Healthcare	GB Market
7D	0%	1.2%	0.4%
1Y	n/a	-27.5%	-1.0%

Return vs Industry: Insufficient data to determine how CLARIP performed against the UK Healthcare industry.

Return vs Market: Insufficient data to determine how CLARIP performed against the UK Market.

Price Volatility

Is CLARIP's price volatile compared to industry and market?
CLARIP volatility
CLARIP Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.5%
Market Average Movement	4.9%
10% most volatile stocks in GB Market	11.3%
10% least volatile stocks in GB Market	2.6%

Stable Share Price: CLARIP has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine CLARIP's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	Sophie Boissard	www.clariane.com

Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.

Clariane SE Fundamentals Summary

How do Clariane's earnings and revenue compare to its market cap?
CLARIP fundamental statistics
Market cap	€228.08m
Earnings (TTM)	€28.04m
Revenue (TTM)	€4.74b

8.1x

P/E Ratio

0.0x

P/S Ratio

Is CLARIP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLARIP income statement (TTM)
Revenue	€4.74b
Cost of Revenue	€3.30b
Gross Profit	€1.44b
Other Expenses	€1.41b
Earnings	€28.04m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

Feb 28, 2024

Earnings per share (EPS)	0.26
Gross Margin	30.33%
Net Profit Margin	0.59%
Debt/Equity Ratio	113.4%

How did CLARIP perform over the long term?

See historical performance and comparison

Dividends

11.7%

Current Dividend Yield

189%

Payout Ratio

CLARIP Stock Overview

Rewards

Risk Analysis

Clariane SE Competitors

AIM:CVSG

UK£661.3m

LSE:SPI

UK£965.1m

LSE:MDC

UK£3.7b

LSE:IDHC

US$218.7m

Price History & Performance

Recent News & Updates

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Recent updates

Clariane Confirms Rumor of Disposal of HAD/SSIAD Business in France

Elevation Healthcare Properties managed by Elevation Advisors signed an agreement to acquire Berkley Care Group Ltd from Clariane SE (ENXTPA:CLARI) for £207 million.

Clariane SE to Report First Half, 2024 Results on Jul 30, 2024

Clariane SE to Report Fiscal Year 2023 Results on Feb 28, 2024

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Clariane Announces Dividend for the Financial Year 2022, Payable on July 13, 2023

Full year 2022 earnings released

Korian (ENXTPA:KORI) acquired Grupo 5 Acción y Gestión Social, S.A. from Corpfin Capital Asesores, S.A., SGEIC and others.

Investor sentiment improved over the past week

Korian to Report First Half, 2023 Results on Jul 27, 2023

High number of new directors

Korian Appoints Philippe Lévêque as Director and Chairman of the Ethics, Quality and CSR Committee

Upcoming dividend of €0.35 per share

High number of new directors

High number of new directors

Korian Proposes Dividend

High number of new directors

Full year 2021 earnings: Revenues in line with analyst expectations

Investor sentiment deteriorated over the past week

High number of new directors

High number of new directors

Icade Santé SAS completed the acquisition of 2 nursing homes in Le Teilleul and Notre-Dame-de-Sanilhac from Korian (ENXTPA:KORI) for €13 million.

High number of new directors

Korian Provides Sales Guidance for the Year 2022

High number of new directors

First half 2021 earnings released: EPS €0.31 (vs €0.13 in 1H 2020)

High number of new directors

Korian (ENXTPA : KORI) acquired a 90% stake in Santa Croce s.r.l.

Korian in Exclusive Talks to Acquire Osny Psychotherapy Centre in Val d’Oise

Icade Santé SAS acquired One Post-Acute Care Facility and Two Nursing Homes from Korian (ENXTPA:KORI).

Korian (ENXTPA:KORI) completed the acquisition of ITA Mental Health from Magnum Capital Industrial Partners.

Korian Approves Dividend, Payable on July 1, 2021

Upcoming dividend of €0.30 per share

Korian Provides Revenue Guidance for the Full Year 2021 and Full Year 2022

Korian (ENXTPA:KORI) signed an agreement to acquire ITA Mental Health from Magnum Capital Industrial Partners.

Full year 2020 earnings released

Revenue beats expectations

Korian (ENXTPA:KORI) acquired unknown minority stake in Viva Son Group.

Korian Demonstrates the Relevance of its Asset Smart Strategy through a Partnership with BNP Paribas Cardif and EDF Invest

New 90-day high: €31.12

Icade SA (ENXTPA:ICAD) agreed to acquire Four Nursing Homes in France from Korian (ENXTPA:KORI) for €33.5 million.

Korian (ENXTPA:KORI) completed the acquisition of Inicea Groupe from Antin Infrastructure Partners S.A.S.

Korian Signs Development Partnership with Aedifica in the Netherlands

Korian has completed a Follow-on Equity Offering in the amount of €400.250658 million.

Korian to Report First Half, 2021 Results on Jul 29, 2021

Korian to Report Fiscal Year 2020 Results on Feb 24, 2021

Korian (ENXTPA:KORI) reached a non binding deal to acquire Inicea Groupe for €360 million.

Korian Announces Executive Changes

Korian (ENXTPA:KORI) entered into an agreement to acquire Five Facilities near Amsterdam from Ontzorgd Wonen Groep B.V.

Korian (ENXTPA:KORI) acquired Santa Marinella.

Shareholder Returns

Price Volatility

About the Company

Clariane SE Fundamentals Summary

8.1x

0.0x

Earnings & Revenue

Dividends

11.7%